Skip to main content
Top

Open Access 29-10-2024 | Liver Transplantation | Original Article

The small-for-size syndrome in living donor liver transplantation: current management

Authors: Luca Del Prete, Cristiano Quintini, Teresa Diago Uso

Published in: Updates in Surgery

Login to get access

Abstract

Small-for-size syndrome poses a significant challenge in living donor liver transplantation, with potentially severe consequences including liver failure and death. This review explores the management strategies for SFSS, starting from the pathophysiology of the disease. SFSS arises from insufficient liver mass in the graft and hyperdynamic circulation in cirrhotic recipients, leading to portal hyperperfusion and subsequent liver injury. Risk factors include graft size, quality, recipient factors, and hemodynamic changes during transplantation.
Hemodynamic monitoring is crucial during living donor liver transplantation to optimize portal vein and hepatic artery flow. Prevention strategies focus on donor-recipient matching and intraoperative graft inflow modulation. Optimizing venous outflow and avoiding portal hyperperfusion is essential. Management of established small-for-size syndrome involves supportive care, pharmacologic interventions, and radiological and surgical options. Pharmacotherapy includes somatostatin analogues, beta-blockers, and vasopressin analogues to reduce portal flow and pressure. Surgical interventions aim to modulate portal flow and mitigate complications. Retransplantation may be necessary in severe cases, guided by persistent graft dysfunction despite liver flow modulations. In conclusion, preventing and managing small-for-size syndrome in living donor liver transplantation requires comprehensive assessment and tailored interventions. Advancements in graft/recipient matching, hemodynamic monitoring, pharmacologic and surgical techniques aiming to inflow modulation have improved outcomes, enabling successful transplantation even with ultra-small grafts.
Literature
1.
go back to reference Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K et al (1999) Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67(2):321–327CrossRefPubMed Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K et al (1999) Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67(2):321–327CrossRefPubMed
2.
go back to reference Dahm F, Georgiev P, Clavien P-A (2005) Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transpl 5(11):2605–2610CrossRef Dahm F, Georgiev P, Clavien P-A (2005) Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transpl 5(11):2605–2610CrossRef
3.
go back to reference Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N et al (2016) Left lobe living donor liver transplantation in adults: What is the safety limit? Liver Transpl 22(12):1666–1675CrossRefPubMed Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N et al (2016) Left lobe living donor liver transplantation in adults: What is the safety limit? Liver Transpl 22(12):1666–1675CrossRefPubMed
4.
go back to reference Humar A, Beissel J, Crotteau S, Cohen M, Lake J, Payne WD (2009) Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transpl 15(2):163–168CrossRefPubMed Humar A, Beissel J, Crotteau S, Cohen M, Lake J, Payne WD (2009) Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transpl 15(2):163–168CrossRefPubMed
5.
go back to reference Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K et al (2006) Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30(8):986–993CrossRefPubMed Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K et al (2006) Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30(8):986–993CrossRefPubMed
6.
7.
go back to reference Ayuse T, Brienza N, O’Donnell CP, Robotham JL (1994) Pressure-flow analysis of portal vein and hepatic artery interactions in porcine liver. Am J Physiol 267(4 Pt 2):H1233-1242PubMed Ayuse T, Brienza N, O’Donnell CP, Robotham JL (1994) Pressure-flow analysis of portal vein and hepatic artery interactions in porcine liver. Am J Physiol 267(4 Pt 2):H1233-1242PubMed
8.
go back to reference Yagi S, Iida T, Hori T, Taniguchi K, Nagahama M, Isaji S et al (2012) Effect of portal haemodynamics on liver graft and intestinal mucosa after small-for-size liver transplantation in swine. Eur Surg Res 48(3):163–170CrossRefPubMed Yagi S, Iida T, Hori T, Taniguchi K, Nagahama M, Isaji S et al (2012) Effect of portal haemodynamics on liver graft and intestinal mucosa after small-for-size liver transplantation in swine. Eur Surg Res 48(3):163–170CrossRefPubMed
9.
go back to reference Troisi RI, Berardi G, Tomassini F, Sainz-Barriga M (2017) Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review. Transpl Rev (Orlando) 31(2):127–135CrossRef Troisi RI, Berardi G, Tomassini F, Sainz-Barriga M (2017) Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review. Transpl Rev (Orlando) 31(2):127–135CrossRef
12.
go back to reference Yeow M, Pang NQ, Muthiah MD, Soon G, Yock-Young D, Bonney GK et al (2022) Impact of donor age on recipient morbidity and mortality after living donor liver transplantation. ANZ J Surg 92(7–8):1867–1872CrossRefPubMed Yeow M, Pang NQ, Muthiah MD, Soon G, Yock-Young D, Bonney GK et al (2022) Impact of donor age on recipient morbidity and mortality after living donor liver transplantation. ANZ J Surg 92(7–8):1867–1872CrossRefPubMed
13.
go back to reference Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y et al (2018) Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg 267(6):1126–1133CrossRefPubMed Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y et al (2018) Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg 267(6):1126–1133CrossRefPubMed
14.
go back to reference Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K et al (2018) Is portal venous pressure modulation still indicated for all recipients in living donor liver transplantation? Liver Transpl 24(11):1578–1588CrossRefPubMed Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K et al (2018) Is portal venous pressure modulation still indicated for all recipients in living donor liver transplantation? Liver Transpl 24(11):1578–1588CrossRefPubMed
15.
go back to reference Knaak M, Goldaracena N, Doyle A, Cattral MS, Greig PD, Lilly L et al (2017) Donor BMI >30 Is not a contraindication for live liver donation. Am J Transpl 17(3):754–760CrossRef Knaak M, Goldaracena N, Doyle A, Cattral MS, Greig PD, Lilly L et al (2017) Donor BMI >30 Is not a contraindication for live liver donation. Am J Transpl 17(3):754–760CrossRef
16.
go back to reference Abdallah A, Salman AA, Sholkamy AA, Salman MA, Omar MG, Youssef A et al (2021) Study of factors affecting small for size syndrome post-adult living donor liver transplantation. Asian J Surg 44(2):452–458CrossRefPubMed Abdallah A, Salman AA, Sholkamy AA, Salman MA, Omar MG, Youssef A et al (2021) Study of factors affecting small for size syndrome post-adult living donor liver transplantation. Asian J Surg 44(2):452–458CrossRefPubMed
17.
go back to reference Tourky MS, Salman AA, Salman MA, Abdelfatah MM, Taha AE, Hagag H et al (2021) Intraoperative factors associated with early recipient death after adult-to-adult living donor liver transplant. Exp Clin Transpl 19(8):817–825CrossRef Tourky MS, Salman AA, Salman MA, Abdelfatah MM, Taha AE, Hagag H et al (2021) Intraoperative factors associated with early recipient death after adult-to-adult living donor liver transplant. Exp Clin Transpl 19(8):817–825CrossRef
18.
go back to reference Bhangui P, Sah J, Choudhary N, Gautam D, Gupta V, Srinivasan T et al (2020) Safe use of right lobe live donor livers with up to 20% macrovesicular steatosis without compromising donor safety and recipient outcome. Transplantation 104(2):308–316CrossRefPubMed Bhangui P, Sah J, Choudhary N, Gautam D, Gupta V, Srinivasan T et al (2020) Safe use of right lobe live donor livers with up to 20% macrovesicular steatosis without compromising donor safety and recipient outcome. Transplantation 104(2):308–316CrossRefPubMed
19.
go back to reference Hakeem AR, Mathew JS, Aunés CV, Mazzola A, Alconchel F, Yoon Y-I et al (2023) Preventing small-for-size syndrome in living donor liver transplantation: guidelines from the ILTS-iLDLT-LTSI consensus conference. Transplantation 107(10):2203–2215PubMed Hakeem AR, Mathew JS, Aunés CV, Mazzola A, Alconchel F, Yoon Y-I et al (2023) Preventing small-for-size syndrome in living donor liver transplantation: guidelines from the ILTS-iLDLT-LTSI consensus conference. Transplantation 107(10):2203–2215PubMed
20.
go back to reference Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS et al (2008) Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 14(9):1273–1280CrossRefPubMed Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS et al (2008) Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 14(9):1273–1280CrossRefPubMed
21.
go back to reference Shoreem H, Gad EH, Soliman H, Hegazy O, Saleh S, Zakaria H et al (2017) Small for size syndrome difficult dilemma: lessons from 10 years single centre experience in living donor liver transplantation. World J Hepatol 9(21):930–944CrossRefPubMed Shoreem H, Gad EH, Soliman H, Hegazy O, Saleh S, Zakaria H et al (2017) Small for size syndrome difficult dilemma: lessons from 10 years single centre experience in living donor liver transplantation. World J Hepatol 9(21):930–944CrossRefPubMed
22.
go back to reference Uchiyama H, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Harimoto N et al (2016) Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl 22(3):305–315CrossRefPubMed Uchiyama H, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Harimoto N et al (2016) Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl 22(3):305–315CrossRefPubMed
23.
go back to reference Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L et al (2009) A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl 15(12):1776–1782CrossRefPubMed Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L et al (2009) A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl 15(12):1776–1782CrossRefPubMed
24.
go back to reference Sethi P, Thillai M, Thankamonyamma BS, Mallick S, Gopalakrishnan U, Balakrishnan D et al (2018) Living donor liver transplantation using small-for-size grafts: does size really matter? J Clin Exp Hepatol 8(2):125–131CrossRefPubMed Sethi P, Thillai M, Thankamonyamma BS, Mallick S, Gopalakrishnan U, Balakrishnan D et al (2018) Living donor liver transplantation using small-for-size grafts: does size really matter? J Clin Exp Hepatol 8(2):125–131CrossRefPubMed
25.
go back to reference Xia L, Qiao Z-Y, Zhang Z-J, Lv Z-C, Tong H, Tong Y et al (2022) Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: the TEA cohort to evaluate long-term post-transplant outcomes. EClinicalMedicine 49:101476CrossRefPubMed Xia L, Qiao Z-Y, Zhang Z-J, Lv Z-C, Tong H, Tong Y et al (2022) Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: the TEA cohort to evaluate long-term post-transplant outcomes. EClinicalMedicine 49:101476CrossRefPubMed
26.
go back to reference Wang L-Y, Lan X, Zhang H, Li H-Y, Liu F, Li B et al (2019) Impact of non-middle hepatic vein reconstruction on the result of low graft-to-recipient weight ratio living donor liver transplantation. Sichuan Da Xue Xue Bao Yi Xue Ban 50(5):760–764PubMed Wang L-Y, Lan X, Zhang H, Li H-Y, Liu F, Li B et al (2019) Impact of non-middle hepatic vein reconstruction on the result of low graft-to-recipient weight ratio living donor liver transplantation. Sichuan Da Xue Xue Bao Yi Xue Ban 50(5):760–764PubMed
27.
go back to reference Fujiki M, Hashimoto K, Quintini C, Aucejo F, Kwon CHD, Matsushima H et al (2022) Living donor liver transplantation with augmented venous outflow and splenectomy: a promised land for small left lobe grafts. Ann Surg 276(5):838–845CrossRefPubMed Fujiki M, Hashimoto K, Quintini C, Aucejo F, Kwon CHD, Matsushima H et al (2022) Living donor liver transplantation with augmented venous outflow and splenectomy: a promised land for small left lobe grafts. Ann Surg 276(5):838–845CrossRefPubMed
28.
go back to reference Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T et al (2005) Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation. Transpl Int 18(8):923–928CrossRefPubMed Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T et al (2005) Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation. Transpl Int 18(8):923–928CrossRefPubMed
29.
go back to reference Kirchner VA, Shankar S, Victor DWI, Tanaka T, Goldaracena N, Troisi RI et al (2023) Management of established small-for-size syndrome in post living donor liver transplantation: medical, radiological, and surgical interventions: guidelines from the ILTS-iLDLT-LTSI consensus conference. Transplantation 107(10):2238CrossRefPubMed Kirchner VA, Shankar S, Victor DWI, Tanaka T, Goldaracena N, Troisi RI et al (2023) Management of established small-for-size syndrome in post living donor liver transplantation: medical, radiological, and surgical interventions: guidelines from the ILTS-iLDLT-LTSI consensus conference. Transplantation 107(10):2238CrossRefPubMed
30.
go back to reference Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P et al (2008) Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation 85(4):554–560CrossRefPubMed Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P et al (2008) Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation 85(4):554–560CrossRefPubMed
31.
go back to reference Jain A, Venkataramanan R, Sharma R, Kwong T, Abt P, Orloff M et al (2008) Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol 48(5):547–552CrossRefPubMed Jain A, Venkataramanan R, Sharma R, Kwong T, Abt P, Orloff M et al (2008) Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol 48(5):547–552CrossRefPubMed
32.
go back to reference Kishino S, Ohno K, Shimamura T, Furukawa H, Todo S (2006) A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transpl 20(4):443–449CrossRef Kishino S, Ohno K, Shimamura T, Furukawa H, Todo S (2006) A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transpl 20(4):443–449CrossRef
33.
go back to reference Liu F, Li Y, Lan X, Wei Y-G, Li B, Yan L-N et al (2009) Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World J Gastroenterol 15(31):3931–3936CrossRefPubMed Liu F, Li Y, Lan X, Wei Y-G, Li B, Yan L-N et al (2009) Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World J Gastroenterol 15(31):3931–3936CrossRefPubMed
34.
go back to reference Bernardi M, Caraceni P, Navickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55(4):1172–1181CrossRefPubMed Bernardi M, Caraceni P, Navickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55(4):1172–1181CrossRefPubMed
35.
go back to reference Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM (2016) Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 16(4):e32636CrossRefPubMed Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM (2016) Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 16(4):e32636CrossRefPubMed
36.
go back to reference Sparrelid E, Gilg S, van Gulik TM (2020) Systematic review of MARS treatment in post-hepatectomy liver failure. HPB (Oxford) 22(7):950–960CrossRefPubMed Sparrelid E, Gilg S, van Gulik TM (2020) Systematic review of MARS treatment in post-hepatectomy liver failure. HPB (Oxford) 22(7):950–960CrossRefPubMed
37.
go back to reference Park C-S, Hwang S, Park H-W, Park Y-H, Lee H-J, Namgoong J-M et al (2012) Role of plasmapheresis as liver support for early graft dysfunction following adult living donor liver transplantation. Transpl Proc 44(3):749–751CrossRef Park C-S, Hwang S, Park H-W, Park Y-H, Lee H-J, Namgoong J-M et al (2012) Role of plasmapheresis as liver support for early graft dysfunction following adult living donor liver transplantation. Transpl Proc 44(3):749–751CrossRef
38.
go back to reference Rajakumar A, Kaliamoorthy I, Rela M, Mandell MS (2017) Small-for-size syndrome: bridging the gap between liver transplantation and graft recovery. Semin Cardiothorac Vasc Anesth 21(3):252–261CrossRefPubMed Rajakumar A, Kaliamoorthy I, Rela M, Mandell MS (2017) Small-for-size syndrome: bridging the gap between liver transplantation and graft recovery. Semin Cardiothorac Vasc Anesth 21(3):252–261CrossRefPubMed
39.
go back to reference Troisi RI, Vanlander A, Giglio MC, Van Limmen J, Scudeller L, Heyse B et al (2019) Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension: a randomized trial. Ann Surg 269(6):1025CrossRefPubMed Troisi RI, Vanlander A, Giglio MC, Van Limmen J, Scudeller L, Heyse B et al (2019) Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension: a randomized trial. Ann Surg 269(6):1025CrossRefPubMed
40.
go back to reference Abraldes JG, Bosch J (2002) Somatostatin and analogues in portal hypertension. Hepatology 35(6):1305–1312CrossRefPubMed Abraldes JG, Bosch J (2002) Somatostatin and analogues in portal hypertension. Hepatology 35(6):1305–1312CrossRefPubMed
41.
go back to reference Ge PS, Runyon BA (2014) The changing role of beta-blocker therapy in patients with cirrhosis. J Hepatol 60(3):643–653CrossRefPubMed Ge PS, Runyon BA (2014) The changing role of beta-blocker therapy in patients with cirrhosis. J Hepatol 60(3):643–653CrossRefPubMed
42.
go back to reference Busani S, Marconi G, Schiavon L, Rinaldi L, Del Buono M, Masetti M et al (2006) Living donor liver transplantation and management of portal venous pressure. Transpl Proc 38(4):1074–1075CrossRef Busani S, Marconi G, Schiavon L, Rinaldi L, Del Buono M, Masetti M et al (2006) Living donor liver transplantation and management of portal venous pressure. Transpl Proc 38(4):1074–1075CrossRef
43.
go back to reference Reddy MS, Kaliamoorthy I, Rajakumar A, Malleeshwaran S, Appuswamy E, Lakshmi S et al (2017) Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl 23(8):1007–1014CrossRefPubMed Reddy MS, Kaliamoorthy I, Rajakumar A, Malleeshwaran S, Appuswamy E, Lakshmi S et al (2017) Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl 23(8):1007–1014CrossRefPubMed
44.
go back to reference Fayed N, Refaat EK, Yassein TE, Alwaraqy M (2013) Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care 28(5):775–782CrossRefPubMed Fayed N, Refaat EK, Yassein TE, Alwaraqy M (2013) Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care 28(5):775–782CrossRefPubMed
45.
go back to reference Mukhtar A, Salah M, Aboulfetouh F, Obayah G, Samy M, Hassanien A et al (2011) The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med 39(6):1329–1334CrossRefPubMed Mukhtar A, Salah M, Aboulfetouh F, Obayah G, Samy M, Hassanien A et al (2011) The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med 39(6):1329–1334CrossRefPubMed
46.
go back to reference Onoe T, Tanaka Y, Ide K, Ishiyama K, Oshita A, Kobayashi T et al (2013) Attenuation of portal hypertension by continuous portal infusion of PGE1 and immunologic impact in adult-to-adult living-donor liver transplantation. Transplantation 95(12):1521–1527CrossRefPubMed Onoe T, Tanaka Y, Ide K, Ishiyama K, Oshita A, Kobayashi T et al (2013) Attenuation of portal hypertension by continuous portal infusion of PGE1 and immunologic impact in adult-to-adult living-donor liver transplantation. Transplantation 95(12):1521–1527CrossRefPubMed
47.
go back to reference Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M et al (2004) The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 51(57):625–629PubMed Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M et al (2004) The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 51(57):625–629PubMed
48.
go back to reference Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y et al (2003) Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications1,2. Transplantation 75(8):1313–1317CrossRefPubMed Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y et al (2003) Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications1,2. Transplantation 75(8):1313–1317CrossRefPubMed
49.
go back to reference Umeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S et al (2008) Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 86(5):673–680CrossRefPubMed Umeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S et al (2008) Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 86(5):673–680CrossRefPubMed
50.
go back to reference Quintini C, D’Amico G, Brown C, Aucejo F, Hashimoto K, Kelly DM et al (2011) Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl 17(6):668–673CrossRefPubMed Quintini C, D’Amico G, Brown C, Aucejo F, Hashimoto K, Kelly DM et al (2011) Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl 17(6):668–673CrossRefPubMed
51.
go back to reference D’Amico G, Partovi S, Del Prete L, Matsushima H, Diago-Uso T, Hashimoto K et al (2023) Proximal splenic artery embolization for refractory ascites and hydrothorax post-liver transplant. Cardiovasc Intervent Radiol 46(4):470–479CrossRefPubMed D’Amico G, Partovi S, Del Prete L, Matsushima H, Diago-Uso T, Hashimoto K et al (2023) Proximal splenic artery embolization for refractory ascites and hydrothorax post-liver transplant. Cardiovasc Intervent Radiol 46(4):470–479CrossRefPubMed
52.
go back to reference Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y et al (2019) Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Am J Transpl 19(10):2783–2794CrossRef Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y et al (2019) Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Am J Transpl 19(10):2783–2794CrossRef
53.
go back to reference Feng A-C, Fan H-L, Chen T-W, Hsieh C-B (2014) Hepatic hemodynamic changes during liver transplantation: a review. World J Gastroenterol 20(32):11131–11141CrossRefPubMed Feng A-C, Fan H-L, Chen T-W, Hsieh C-B (2014) Hepatic hemodynamic changes during liver transplantation: a review. World J Gastroenterol 20(32):11131–11141CrossRefPubMed
54.
go back to reference Yoshizumi T, Mori M (2020) Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today 50(1):21–29CrossRefPubMed Yoshizumi T, Mori M (2020) Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today 50(1):21–29CrossRefPubMed
55.
go back to reference Badawy A, Hamaguchi Y, Satoru S, Kaido T, Okajima H, Uemoto S (2017) Evaluation of safety of concomitant splenectomy in living donor liver transplantation: a retrospective study. Transpl Int 30(9):914–923CrossRefPubMed Badawy A, Hamaguchi Y, Satoru S, Kaido T, Okajima H, Uemoto S (2017) Evaluation of safety of concomitant splenectomy in living donor liver transplantation: a retrospective study. Transpl Int 30(9):914–923CrossRefPubMed
56.
go back to reference Yoshizumi T, Itoh S, Shimokawa M, Inokuchi S, Harada N, Takeishi K et al (2021) Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol 74(2):372–379CrossRefPubMed Yoshizumi T, Itoh S, Shimokawa M, Inokuchi S, Harada N, Takeishi K et al (2021) Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol 74(2):372–379CrossRefPubMed
57.
go back to reference Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A et al (2010) Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl 16(6):718–728CrossRefPubMed Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A et al (2010) Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl 16(6):718–728CrossRefPubMed
58.
go back to reference Lauro A, Diago Uso T, Quintini C, Di Benedetto F, Dazzi A, De Ruvo N et al (2007) Adult-to-adult living donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow. Transpl Proc 39(6):1874–1876CrossRef Lauro A, Diago Uso T, Quintini C, Di Benedetto F, Dazzi A, De Ruvo N et al (2007) Adult-to-adult living donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow. Transpl Proc 39(6):1874–1876CrossRef
59.
go back to reference Vasavada B, Chen CL, Zakaria M (2014) Using low graft/recipient’s body weight ratio graft with portal flow modulation an effective way to prevent small-for-size syndrome in living-donor liver transplant: a retrospective analysis. Exp Clin Transpl 12(5):437–442 Vasavada B, Chen CL, Zakaria M (2014) Using low graft/recipient’s body weight ratio graft with portal flow modulation an effective way to prevent small-for-size syndrome in living-donor liver transplant: a retrospective analysis. Exp Clin Transpl 12(5):437–442
60.
go back to reference Wang H, Ikegami T, Harada N, Yoshizumi T, Soejima Y, Uchiyama H et al (2015) Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation. Surg Today 45(8):979–985CrossRefPubMed Wang H, Ikegami T, Harada N, Yoshizumi T, Soejima Y, Uchiyama H et al (2015) Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation. Surg Today 45(8):979–985CrossRefPubMed
61.
go back to reference Moon D-B, Lee S-G, Hwang S, Ahn C-S, Kim K-H, Ha T-Y et al (2019) Splenic devascularization can replace splenectomy during adult living donor liver transplantation - a historical cohort study. Transpl Int 32(5):535–545CrossRefPubMed Moon D-B, Lee S-G, Hwang S, Ahn C-S, Kim K-H, Ha T-Y et al (2019) Splenic devascularization can replace splenectomy during adult living donor liver transplantation - a historical cohort study. Transpl Int 32(5):535–545CrossRefPubMed
62.
go back to reference Ito K, Akamatsu N, Ichida A, Ito D, Kaneko J, Arita J et al (2016) Splenectomy is not indicated in living donor liver transplantation. Liver Transpl 22(11):1526–1535CrossRefPubMed Ito K, Akamatsu N, Ichida A, Ito D, Kaneko J, Arita J et al (2016) Splenectomy is not indicated in living donor liver transplantation. Liver Transpl 22(11):1526–1535CrossRefPubMed
63.
go back to reference Mukhtar A, Dabbous H (2016) Modulation of splanchnic circulation: role in perioperative management of liver transplant patients. World J Gastroenterol 22(4):1582–1592CrossRefPubMed Mukhtar A, Dabbous H (2016) Modulation of splanchnic circulation: role in perioperative management of liver transplant patients. World J Gastroenterol 22(4):1582–1592CrossRefPubMed
64.
go back to reference Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S (2008) Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transpl 8(4):847–853CrossRef Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S (2008) Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transpl 8(4):847–853CrossRef
65.
go back to reference Soin AS, Yadav SK, Saha SK, Rastogi A, Bhangui P, Srinivasan T et al (2019) Is portal inflow modulation always necessary for successful utilization of small volume living donor liver grafts? Liver Transpl 25(12):1811–1821CrossRefPubMed Soin AS, Yadav SK, Saha SK, Rastogi A, Bhangui P, Srinivasan T et al (2019) Is portal inflow modulation always necessary for successful utilization of small volume living donor liver grafts? Liver Transpl 25(12):1811–1821CrossRefPubMed
66.
go back to reference Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S et al (2020) A multicenter japanese survey assessing the long-term outcomes of liver retransplantation using living donor grafts. Transplantation 104(4):754CrossRefPubMed Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S et al (2020) A multicenter japanese survey assessing the long-term outcomes of liver retransplantation using living donor grafts. Transplantation 104(4):754CrossRefPubMed
67.
go back to reference Wong TC-L, Fung JYY, Cui TYS, Sin SL, Ma KW, She BWH et al (2021) The risk of going small: lowering GRWR and overcoming small-for-size syndrome in adult living donor liver transplantation. Ann Surg 274(6):e1260–e1268CrossRefPubMed Wong TC-L, Fung JYY, Cui TYS, Sin SL, Ma KW, She BWH et al (2021) The risk of going small: lowering GRWR and overcoming small-for-size syndrome in adult living donor liver transplantation. Ann Surg 274(6):e1260–e1268CrossRefPubMed
68.
go back to reference Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP et al (2021) Retransplantation after living donor liver transplantation: data from the adult to adult living donor liver transplantation study. Transplantation 105(6):1297–1302CrossRefPubMed Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP et al (2021) Retransplantation after living donor liver transplantation: data from the adult to adult living donor liver transplantation study. Transplantation 105(6):1297–1302CrossRefPubMed
69.
go back to reference Bittermann T, Shaked A, Goldberg DS (2017) When living donor liver allografts fail: exploring the outcomes of retransplantation using deceased donors. Am J Transpl 17(4):1097–1102CrossRef Bittermann T, Shaked A, Goldberg DS (2017) When living donor liver allografts fail: exploring the outcomes of retransplantation using deceased donors. Am J Transpl 17(4):1097–1102CrossRef
71.
go back to reference Chok KSH, Chan ACY, Fung JYY, Dai WC, Cheung TT, Lo CM (2017) Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation. Hepatol Int 11(6):517–522CrossRefPubMed Chok KSH, Chan ACY, Fung JYY, Dai WC, Cheung TT, Lo CM (2017) Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation. Hepatol Int 11(6):517–522CrossRefPubMed
72.
go back to reference Moon D-B, Hwang S, Ahn C-S, Ha T-Y, Song G-W, Jung D-H et al (2021) Living donor liver transplantation-associated retransplantation in adult patients. Annals of Liver Transpl 1(1):48–57CrossRef Moon D-B, Hwang S, Ahn C-S, Ha T-Y, Song G-W, Jung D-H et al (2021) Living donor liver transplantation-associated retransplantation in adult patients. Annals of Liver Transpl 1(1):48–57CrossRef
73.
go back to reference Troisi R, Ricciardi S, Smeets P, Petrovic M, Van Maele G, Colle I et al (2005) Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transpl 5(6):1397–1404CrossRef Troisi R, Ricciardi S, Smeets P, Petrovic M, Van Maele G, Colle I et al (2005) Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transpl 5(6):1397–1404CrossRef
74.
go back to reference Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL et al (2010) Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl 16(5):649–657CrossRefPubMed Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL et al (2010) Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl 16(5):649–657CrossRefPubMed
75.
go back to reference Boillot O, Delafosse B, Méchet I, Boucaud C, Pouyet M (2002) Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 359(9304):406–407CrossRefPubMed Boillot O, Delafosse B, Méchet I, Boucaud C, Pouyet M (2002) Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 359(9304):406–407CrossRefPubMed
Metadata
Title
The small-for-size syndrome in living donor liver transplantation: current management
Authors
Luca Del Prete
Cristiano Quintini
Teresa Diago Uso
Publication date
29-10-2024
Publisher
Springer International Publishing
Published in
Updates in Surgery
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-024-01964-7
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now